128 related articles for article (PubMed ID: 9406239)
1. A new cellular target for mitomycin C: a case for mitochondrial DNA.
Pritsos CA; Briggs LA; Gustafson DL
Oncol Res; 1997; 9(6-7):333-7. PubMed ID: 9406239
[TBL] [Abstract][Full Text] [Related]
2. Disruption of normal cellular bioenergetics in Balb/c mice by mitomycin C.
Pritsos CA; Briggs LA
Br J Cancer Suppl; 1996 Jul; 27():S15-8. PubMed ID: 8763838
[TBL] [Abstract][Full Text] [Related]
3. Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development.
Phillips RM; Burger AM; Loadman PM; Jarrett CM; Swaine DJ; Fiebig HH
Cancer Res; 2000 Nov; 60(22):6384-90. PubMed ID: 11103802
[TBL] [Abstract][Full Text] [Related]
4. Effect of change in cellular GSH levels on mitochondrial damage and cell viability loss due to mitomycin c in small cell lung cancer cells.
Lee CS; Park SY; Ko HH; Han ES
Biochem Pharmacol; 2004 Nov; 68(9):1857-67. PubMed ID: 15450951
[TBL] [Abstract][Full Text] [Related]
5. DT-diaphorase as a target enzyme for biochemical modulation of mitomycin C.
Saeki S; Nishiyama M; Toge T
Hiroshima J Med Sci; 1995 Sep; 44(3):55-63. PubMed ID: 8567314
[TBL] [Abstract][Full Text] [Related]
6. In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin.
Cheung RY; Rauth AM; Ronaldson PT; Bendayan R; Wu XY
Eur J Pharm Biopharm; 2006 Apr; 62(3):321-31. PubMed ID: 16330194
[TBL] [Abstract][Full Text] [Related]
7. [Intraperitoneal chemotherapy with mitomycin C bound to activated carbon nanoparticles for nude mice bearing human gastric carcinoma].
Qu QL; Zhang YG; Yang LZ; Sun L
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):257-60. PubMed ID: 16875622
[TBL] [Abstract][Full Text] [Related]
8. A diffusible resistance factor(s) in spontaneous mitomycin resistant mammalian cancer cells.
Wan ZG; Kobayashi H; Hayakawa A; Ishigaki T
Nagoya J Med Sci; 1998 May; 61(1-2):37-45. PubMed ID: 9664765
[TBL] [Abstract][Full Text] [Related]
9. [Cytotoxic effect of oncolytic virus combined with mitomycin against human bladder cancer cells in vitro and in vivo].
Zhao GZ; Tan WL; Zheng SB; Wu YD; Xie Y; Zhu WH
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1623-5, 1628. PubMed ID: 17121717
[TBL] [Abstract][Full Text] [Related]
10. [Synergistic antitumor effect of sodium caffeate and mitomycin].
Xu F; Song DQ; Zhen YS
Yao Xue Xue Bao; 2002 Jun; 37(6):405-8. PubMed ID: 12579792
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
Schwartz GK; Farsi K; Maslak P; Kelsen DP; Spriggs D
Clin Cancer Res; 1997 Sep; 3(9):1467-72. PubMed ID: 9815832
[TBL] [Abstract][Full Text] [Related]
12. Relative contributions of mouse liver subcellular fractions to the bioactivation of mitomycin C at various pH levels.
Briggs LA; Pritsos CA
Biochem Pharmacol; 1999 Nov; 58(10):1609-14. PubMed ID: 10535752
[TBL] [Abstract][Full Text] [Related]
13. Maitake D-Fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice.
Kodama N; Murata Y; Asakawa A; Inui A; Hayashi M; Sakai N; Nanba H
Nutrition; 2005 May; 21(5):624-9. PubMed ID: 15850970
[TBL] [Abstract][Full Text] [Related]
14. Effects of mitomycin C alone and in combination with X-rays on EMT6 mouse mammary tumors in vivo.
Rockwell S
J Natl Cancer Inst; 1983 Oct; 71(4):765-71. PubMed ID: 6413743
[TBL] [Abstract][Full Text] [Related]
15. Polymeric prodrugs of mitomycin C designed for tumour tropism and sustained activation.
Seymour LW; Soyez H; De Marre A; Shoaibi MA; Schacht EH
Anticancer Drug Des; 1996 Jul; 11(5):351-65. PubMed ID: 8765529
[TBL] [Abstract][Full Text] [Related]
16. Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells.
Kang YH; Lee KA; Ryu CJ; Lee HG; Lim JS; Park SN; Paik SG; Yoon DY
Cancer Lett; 2006 Jun; 237(1):33-44. PubMed ID: 16019139
[TBL] [Abstract][Full Text] [Related]
17. Effect of NDGA on beef heart mitochondria and EMT6 mouse mammary carcinoma cells.
Shi L; Pardini RS
Res Commun Mol Pathol Pharmacol; 1995 Nov; 90(2):235-54. PubMed ID: 8747792
[TBL] [Abstract][Full Text] [Related]
18. [Effect of combination of glutamine and mitomycin C on human gastric carcinoma cell strain MGC-803].
Peng WZ; Yu JC; Liu YQ; Kang WM; Fan YP; Guo WD; Zhang Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):345-9. PubMed ID: 16900630
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver.
Larosche I; Lettéron P; Fromenty B; Vadrot N; Abbey-Toby A; Feldmann G; Pessayre D; Mansouri A
J Pharmacol Exp Ther; 2007 May; 321(2):526-35. PubMed ID: 17277197
[TBL] [Abstract][Full Text] [Related]
20. Polybutylcyanoacrylate nanoparticles as a carrier for mitomycin C in rabbits bearing VX2-liver tumor.
Xi-Xiao Y; Jan-Hai C; Shi-Ting L; Dan G; Xv-Xin Z
Regul Toxicol Pharmacol; 2006 Dec; 46(3):211-7. PubMed ID: 17010489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
